Search…

Lates News

20/09/2025

On September 19th local time, MapLight Therapeutics, a clinical-stage biopharmaceutical company supported by Novo Nordisk, filed for a US IPO. The documents show that the company's lead candidate products include two drugs for treating schizophrenia and psychosis associated with Alzheimer's disease (ADP).

Latest

1 m ago

The number of tourists traveling during the National Day holiday increased by 130% year-on-year. During this National Day holiday, Chinese tourists visited 690 cities around the world.

1 m ago

Ruide Intelligent: Actively laying out research and development in the fields of AI health management and energy management.

2 m ago

Citibank strategists remain bearish on the US dollar, expecting the euro/dollar to rise from the current level of around 1.1750 to 1.20 by the end of this year. Citibank also predicts that the dollar against the yen will weaken, with the dollar/yen falling to 135 by the end of 2026, a decrease of about 9%.

2 m ago

Citigroup strategists are still bearish on the US dollar, expecting the euro/dollar to rise from the current level of around 1.1750 to 1.20 by the end of this year. Citigroup also predicts that the US dollar against the Japanese yen will weaken, with the dollar/yen falling to 135 by the end of 2026, a decline of about 9%.

7 m ago

Musk: XAI will certainly raise funds in the coming months, but not right now.

See all latest